Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Day: February 17, 2012
Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up
By: shaunaharte
Ranibizumab Outcomes at 2 Years: Are They Holding Up?
The 2-year follow-up results are in for intravitreal ranibizumab in the treatment of diabetic macular edema. Medscape Ophthalmology
Absorption of Iron from Ferritin Is Independent of Heme Iron and Ferrous Salts in Women and Rat Intestinal Segments.
By: egoldsmith